![](/img/cover-not-exists.png)
VU6007477, a novel M1 PAM based on a pyrrolo[2,3-b]pyridine carboxamide core devoid of cholinergic adverse events
Engers, Julie L, Childress, Elizabeth S, Long, Madeline F, Capstick, Rory A, Luscombe, Vincent B, Cho, Hyekyung P., Dickerson, Jonathan W, Rook, Jerri M., Blobaum, Anna L., Niswender, Colleen M, EngerLanguage:
english
Journal:
ACS Medicinal Chemistry Letters
DOI:
10.1021/acsmedchemlett.8b00261
Date:
September, 2018
File:
PDF, 969 KB
english, 2018